» Articles » PMID: 1933902

A Germ Line Mutation in Exon 5 of the P53 Gene in an Extended Cancer Family

Overview
Journal Cancer Res
Specialty Oncology
Date 1991 Dec 1
PMID 1933902
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Germ line p53 point mutations have been reported for some families with Li-Fraumeni syndrome, a syndrome characterized by a dominantly inherited increased susceptibility for the development of early age of onset neoplasms of diverse origin in multiple family members. All of the initially reported p53 germ line mutations have been found exclusively within a single conserved, nonpolymorphic region of the gene between condons 245 and 258. The restricted distribution of these inherited mutations has led to speculation that germ line p53 mutations have unique properties [B. Vogelstein, Nature (Lond.), 348: 681-682, 1990]. We report here on the identification of a p53 germ line mutation at codon 133 (ATG----ACG) in nine members of an extended Li-Fraumeni syndrome family. This mutation leads to an amino acid substitution in the protein and is shown to completely cosegregate with Li-Fraumeni syndrome associated cancer in this family. Its location extends the region of the p53 gene where inherited mutations predisposing to cancer are observed and suggests that their distribution may be diverse.

Citing Articles

Li-Fraumeni syndrome in Tunisian carriers with different and rare tumor phenotype: genotype-phenotype correlation.

Sassi H, Meddeb R, Cherif M, Nasr C, Riahi A, Hannachi S BMC Med Genomics. 2022; 15(1):44.

PMID: 35246108 PMC: 8895785. DOI: 10.1186/s12920-022-01189-w.


Hematologic malignancies and Li-Fraumeni syndrome.

Swaminathan M, Bannon S, Routbort M, Naqvi K, Kadia T, Takahashi K Cold Spring Harb Mol Case Stud. 2019; 5(1).

PMID: 30709875 PMC: 6371746. DOI: 10.1101/mcs.a003210.


Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome : current status of clinical applications and future directions.

Sorrell A, Espenschied C, Culver J, Weitzel J Mol Diagn Ther. 2013; 17(1):31-47.

PMID: 23355100 PMC: 3627545. DOI: 10.1007/s40291-013-0020-0.


Effects of measured susceptibility genes on cancer risk in family studies.

Wu C, Strong L, Shete S Hum Genet. 2009; 127(3):349-57.

PMID: 20039063 PMC: 2918266. DOI: 10.1007/s00439-009-0774-y.


Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk.

Hwang S, Lozano G, Amos C, Strong L Am J Hum Genet. 2003; 72(4):975-83.

PMID: 12610779 PMC: 1180359. DOI: 10.1086/374567.